Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan

NCT02977312 · clinicaltrials.gov ↗

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Myeloid Leukemia, Chronic Phase

Interventions

DRUG: Imatinib

Sponsor

Hikma Pharmaceuticals LLC